Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) EBIAT (2016 - 2020)

Historic EBIAT for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to -$879000.0.

  • Glucotrack's EBIAT fell 11366.33% to -$879000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$2.7 million, marking a year-over-year decrease of 17667.8%. This contributed to the annual value of -$7.1 million for FY2023, which is N/A changed from last year.
  • Per Glucotrack's latest filing, its EBIAT stood at -$879000.0 for Q4 2020, which was down 11366.33% from -$509000.0 recorded in Q3 2020.
  • In the past 5 years, Glucotrack's EBIAT registered a high of $18.0 million during Q4 2017, and its lowest value of -$2.6 million during Q3 2017.
  • Over the past 5 years, Glucotrack's median EBIAT value was -$1.1 million (recorded in 2016), while the average stood at $135961.8.
  • Its EBIAT has fluctuated over the past 5 years, first skyrocketed by 168010.73% in 2017, then crashed by 15529.04% in 2019.
  • Glucotrack's EBIAT (Quarter) stood at -$1.1 million in 2016, then surged by 1680.11% to $18.0 million in 2017, then tumbled by 107.4% to -$1.3 million in 2018, then soared by 582.88% to $6.4 million in 2019, then tumbled by 113.66% to -$879000.0 in 2020.
  • Its EBIAT stands at -$879000.0 for Q4 2020, versus -$509000.0 for Q3 2020 and -$574000.0 for Q2 2020.